Total Search Results for "{{searchedParams.q}}" : {{searchedData.data.hits.total}}
{{item.content_type}}
No search results for this term, please try again.

Tae Eun Park , PharmD, BCPS

Assistant Professor, Pharmacy Practice

Tae Park 2
  • Office: 2090 Adam Clayton Powell Jr. Blvd, Suite 603H, New York, NY 10027
  • Campus:
    Touro College of Pharmacy
  • Phone:
    212-851-1192 ext 42561
  • Email:
    tae.park3@touro.edu

Dr. Park received her Doctor of Pharmacy degree from Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey. She completed ASHP-accredited PGY1 Pharmacy Practice Residency at the Hospital of Saint Raphael (currently known as Yale-New Haven Hospital – Saint Raphael) in New Haven, CT and ASHP-accredited PGY2 Infectious Diseases Pharmacy Residency at the State University of New York (SUNY) Downstate Medical Center in Brooklyn, NY. Prior to joining Touro College of Pharmacy, Dr. Park was a faculty at Fairleigh Dickinson University School of Pharmacy in Florham Park, NJ where she was involved in the development and delivery of various courses including Infectious Diseases, Pulmonary/ENT, autoimmune diseases/rare diseases, and patient care labs.

Dr. Park joins Touro College of Pharmacy with a practice site at the SUNY Downstate Medical Center where she will be serving as the PGY2 Infectious Diseases Pharmacy Residency Program Director. 

Education

PharmD, Ernest Mario School of Pharmacy, Rutgers, NJ; 2011

Residencies:
Post-Graduate Year 1 (PGY1) Pharmacy Practice Residency: Hospital of Saint Raphael (Currently known as Yale-New Haven Hospital – Saint Raphael)

Post-Graduate Year 2 (PGY2) Infectious Diseases Pharmacy Residency: State University of New York (SUNY) Downstate Medical Center

 

Clinical Specialty

Infectious Diseases

Research

Methicillin-resistant Staphylococcus aureus (MRSA); carbapenem-resistant gram-negative bacteria; Human Immunodeficiency Virus (HIV)

Academic and Professional Honors

Recognition of contributions to teaching and learning as a member of the Faculty Development Committee, Florham Campus at Fairleigh Dickinson University, June 2015

Certificate of appreciation for American Pharmacists Association (APhA) – Academy of Student Pharmacists (ASP) active faculty involvement, Fairleigh Dickinson University School of Pharmacy, May 2015

Recognition of contributions to teaching and learning as a member of the Faculty Development Committee, Florham Campus at Fairleigh Dickinson University, May 2014

American College of Clinical Pharmacy (AACP) Infectious Diseases Practice and Research Networks (PRN) Travel Award, September 2013

The HIV Pharmacy Research Award, New York State Council of Health-System Pharmacists Research and Education Foundation (NYSCHP-REF), February 2013

Professional Service

American College of Clinical Pharmacy (ACCP)
American Society for Microbiology (ASM)
American Society of Health-System Pharmacists (ASHP)
Society of Infectious Diseases Pharmacists (SIDP)
Peer reviewer, Journal of the International Association of Providers of AIDS Care
Peer reviewer, New Jersey Journal of Pharmacy

Teaching responsibilities

PHRN 655: Emerging Issues III
PHRN 688: Advanced Pathophysiology and Pharmacotherapeutics II
PHRN 781: Comprehensive Pharmacotherapy Patient Care Management
PHRN 784: Pharmacotherapy
PHRN 828: Grand Rounds III
PHRN 746: internal Medicine (APPE core)
PHRN 860: Acute Care (APPE core)

Publications

Peer reviewed journal publications

Ozdener AE, Park TE, Kalabalik J, Gupta R. The future of pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection. Expert Rev Anti Infect Ther 2017;15(5):467-81.

Selevany A, Kalabalik J, Park TE. Use of isavuconazonium sulfate for the treatment of invasive fungal diseases. New Jersey Journal of Pharmacy 2017;XCI(1):11-4.

Szmuc P, Kalabalik J, Park TE. Review of rilpivirine/emtricitabine/tenofovir alafenamide for HIV-infection.   New Jersey Journal of Pharmacy 2016;LXXXX(3):10-1.

Park TE, Kalabalik J. Use of raltegravir in HIV-infected pregnant women. New Jersey Journal of Pharmacy 2016;LXXXX(1): 28-31.

Sharma R, Park TE, Moy S. Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination for the treatment of resistant gram-negative organisms. Clin Ther 2016;38(3):431-44.

Park TE, Yusuff J, Sharma R. Use of aspirin and statins for the primary prevention of myocardial infarction and stroke in patients with human immunodeficiency virus infection. Int J STD AIDS 2016;27(6):447-52.

Park TE, Mohamed A, Kalabalik J, Sharma R. Review of integrase strand transfer inhibitors for the treatment of human immunodeficiency virus infection. Expert Rev Anti Infect Ther 2015;13(10):1195-212.        

Book chapters

Park TE. How steroids work. In: Standora JE, Bogomolnik A, Slugocki M. Steroids: history, science, and issues (the story of a drug). ABC-CLIO, LLC; Santa Barbara, CA; 2017: 65-75.

Abstracts

Ocheretyaner E, Yusuff J, Park TE. Immunologic and virologic response to antiretroviral therapy in treatment-naïve, HIV-infected elderly patients. American Society for Microbiology (ASM) Microbe 2017; June 1-5, 2017; New Orleans, LA.

Park TE, Sharma R. Clinical and microbiological outcomes of polymyxin B in renal insufficiency. 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); Sept 5-9, 2014; Washington, D.C.: Poster number K-1016.

Rattinger GB, Rivkin AM, Mohamed A, Carbone A, Elk N, Giordano P, Kim D, Park TE, Avaltroni MJ. Assessing P2-pharmacy students’ ability to identify drug-related problems using different methods. American Association of Colleges of Pharmacy (AACP) Annual Meeting; July 26-30, 2014; Grapevine, TX: Poster number 78.

Park TE, Augenbraun M, Asheroff A, Sharma R. Value of methicillin-resistant Staphylococcus aureus (MRSA) and carbapenem-resistant Enterobacteriaceae (CRE) surveillance in predicting subsequent infections. American College of Clinical Pharmacy (ACCP) Annual Meeting; Oct 13-16, 2013; Albuquerque, NM: Poster number 116.

Park TE, Yusuff J, Sharma R. Use of aspirin and statins for primary prevention of myocardial infarction and stroke in patients with human immunodeficiency virus (HIV). 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); Sept 10-13, 2013; Denver, CO: Poster number H-1257.

Park TE, Yusuff J, Sharma R. Current trend in the prevention of myocardial infarction and stroke in human immunodeficiency virus (HIV) patients. 47th American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting; Dec 2-6, 2012; Las Vegas, NV: Poster number 7-250.

Park TE, Lindain E. Evaluation of thromboprophylaxis in an orthopedic patient population at the Hospital of Saint Raphael. 46th American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting; Dec 4-8, 2011; New Orleans, LA: Poster number 6-076.

Platform presentations

Value of methicillin-resistant Staphylococcus aureus (MRSA) and carbapenem-resistant Enterobacteriaceae (CRE) surveillance in predicting subsequent infections. American College of Clinical Pharmacy (ACCP) Annual Meeting Infectious Diseases Practice and Research Network (PRN) Business Meeting and Networking Forum; Oct 13-16, 2013; Albuquerque, NM.

Role of aztreonam in beta-lactam allergy for nosocomial infections. 31st Eastern States Conference; May 2-4, 2012; Hershey, PA.

Continuing education lectures

Pre-exposure prophylaxis (PrEP) for HIV prevention. Long Island University Arnold & Marie College of Pharmacy and Health Sciences; April 23, 2017; East Elmhurst, NY.

The impact of aging on HIV. Long Island University Arnold & Marie College of Pharmacy and Health Sciences; April 7, 2013; East Elmhurst, NY.